EpiVax, Inc. - Informatics and Immunology
  • Our Company
    • Company Overview
    • Corporate Responsibility
    • Mission, Vision & Values
    • Team
    • Careers
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • EPV-CoV19: HCW Vaccine
    • BioDefense Vaccines
    • Tregitope: Immunomodulation Power Tool
    • Deimmunization Projects
  • Vaccine Services
    • Vaccine Services
    • COVID-19 Coverage
  • Immunogenicity Assessment
    • Immunogenicity Assessment Overview
    • ISPRI Web-based Immunogenicity Assessment
    • PreDeFT Analysis
    • JanusMatrix Analysis
    • High Throughput Antibody Immunogenicity Analysis
    • PANDA Screening
    • ISPRI for Host Cell Proteins
    • iVAX: Web-based Vaccine Design
    • PreVAX Analysis
  • Deimmunization
  • Lab Services
    • Lab Services Overview
    • T Cell Assays
    • HLA Binding Assays
    • HLA Transgenic Mice
    • In Vitro Immunization Protocol (IVIP)
  • Press Room
    • Press Room
    • Events
      • Webinars
    • Publication & Poster Search
    • Client Testimonials
    • Thinking Out Loud (Blog)
  • Contact Us
Select Page
November Newsletter: The What If Machine sees into the Future

November Newsletter: The What If Machine sees into the Future

by Danielle Medeiros | Oct 27, 2020 | Thinking Out Loud -Blog

The What If Machine, as applied to Immunogenicity Well Hello Again! Our PANDA program is back in the news. Having just completed validation studies on Salmon Calcitonin and Teriparatide,  we’re back in the business of predicting the future with the What If...
September newsletter – Generic PANDA monium!

September newsletter – Generic PANDA monium!

by Danielle Medeiros | Oct 2, 2020 | Thinking Out Loud -Blog

Generic PANDAmonium I have been hanging out with an old dog – eight year old Jack, during the COVID lockdown. If you are a dog during COVID-19, long walks, lots of snuggles on the couch during Zoom meetings, what’s not to like? Hence the theme of my latest...
Time for T? Or, Are T-Cell-Driven Vaccines the Answer to COVID-19?

Time for T? Or, Are T-Cell-Driven Vaccines the Answer to COVID-19?

by Danielle Medeiros | Aug 24, 2020 | Featured, Thinking Out Loud -Blog

Time for T? Or Plan B for Operation Warp Speed? Six months ago, we asked if vaccine makers were rushing to “check the box” rather than spending time designing an effective vaccine (here is another link showing ‘how to”). And have you noticed that all of...
Six months in, are we any closer to a vaccine?

Six months in, are we any closer to a vaccine?

by Danielle Medeiros | Jul 24, 2020 | News, Thinking Out Loud -Blog

Are we “Checking the Box” or Making Vaccines that work? We need a COVID-19 vaccine! From China to the US to Europe and even Africa, scientists  are working tirelessly, if not at “warp speed”, to develop and test more than one COVID-19...
Spy Vs Spy and … Making Better B-cell Derived Antibodies for COVID-19

Spy Vs Spy and … Making Better B-cell Derived Antibodies for COVID-19

by Danielle Medeiros | May 12, 2020 | Thinking Out Loud -Blog

Pepcid: From Poor Man’s Cure to $20M COVID-19 Trial Remember Hydrocychloroquine?  The drug that doesn’t work for COVID-19? Well, here’s some good news for you. A crazy rock climber/mountain rescue nut named Michael Callahan and a brilliant group of...
Press Release: PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 Vaccine

Press Release: PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 Vaccine

by Danielle Medeiros | Apr 15, 2020 | News, Thinking Out Loud -Blog

Originally published via PR Newswire  GOLDEN, Colo., April 14, 2020 /PRNewswire/ — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free injection system will be used to deliver a COVID-19 vaccine...
« Older Entries
Next Entries »

Recent Posts

  • AAPS BPABC Community Presentation: In silico Immunogenicity Prediction for Protein and Peptide Therapeutics
  • IAVI Report Revisited: Lessons from HIV research for SARS-COV-2 vaccine design
  • ConvergenceRI: Truly a Beautiful Day in the Neighborhood
  • February Newsletter: Jack as Co-pilot and Zoom buddy
  • EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)

Categories

  • EpiVax Immunoncology
  • Events
  • Featured
  • News
  • Thinking Out Loud -Blog
  • Uncategorized
  • Webinars

Discover

  • Vaccine Services
  • Immunogenicity Assessment
  • Deimmunization
  • Lab Services
  • Pipeline

About

  • Our Company
  • Press Room
  • Events
  • Publication & Poster Search
  • Thinking Out Loud (Blog)
  • Contact Us

Connect

© 2021 EpiVax, Inc. – Informatics and Immunology, All rights reserved. • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 • fax: 401.272.7562